The global cardiovascular repair and reconstruction devices market size was valued at USD 3.9 billion in 2025 and is projected to grow from USD 4.2 billion in 2026 to USD 6.3 billion by 2033, at a CAGR of 6.1% from 2026 to 2033. North America dominated the market, accounting for a revenue share of 50.0% in 2025. The increasing prevalence of cardiovascular diseases worldwide is due to factors such as inactive lifestyles, poor diets, and aging populations.
The need for cardiovascular repair and reconstruction devices has increased significantly. Innovations in device design and function, along with improvements in surgical techniques, are leading to more effective and efficient treatments. In addition, the expansion of healthcare infrastructure in emerging economies is facilitating greater access to these treatments.
In March 2026, Philips received U.S. FDA 510(k) clearance for its EchoNavigator R5.0 with DeviceGuide, an imaging and visualization solution that uses artificial intelligence (AI) to assist physicians during complex minimally invasive mitral valve repair procedures. The system enables real-time tracking and visualization of repair devices during surgery by integrating advanced imaging, AI-based guidance, and 3D visualization within a unified workflow. This development illustrates ongoing advancements in cardiovascular repair procedures, where advanced device guidance technologies enhance procedural precision, reduce complexity in valve repair interventions, and improve surgical outcomes.
The market is poised for substantial growth, driven by emerging trends in healthcare, including the application of AI in diagnostics and treatment planning, advancements in regenerative medicine and tissue engineering, and the rise of personalized medicine and therapy. Furthermore, the growing importance of biochemicals as essential components of treatment regimens is expected to fuel continued market expansion.
A study published in Circulation, the American Heart Association journal, in June 2024 highlighted the growing role of biomaterials and bioactive components in cardiovascular repair strategies. This includes engineered heart tissues, regenerative scaffolds, and biologically active coatings used in cardiac reconstruction therapies. The study emphasized that biochemical and bioengineered materials are increasingly being incorporated into cardiovascular repair devices to enhance tissue regeneration, improve biocompatibility, and support the functional recovery of damaged heart tissue. This reflects a broader shift toward combining device-based interventions with biochemical and regenerative therapeutic approaches in cardiovascular treatment.
Increased investment in research and development for peripheral arterial disease (PAD) holds significant promise for improving treatment efficacy and developing innovative solutions. Currently, angioplasty is the primary intervention for PAD; however, atherectomy offers an alternative method for addressing atherosclerotic plaque buildup. The focus on minimally invasive endovascular techniques to treat arterial blockages is driving innovation in the medical device industry and is expected to propel market growth in the coming years.
▪ Hemodialysis Access Graft
▪ Peripheral Vascular Graft
▪ Canada
▪ Mexico
▪ UK
▪ France
▪ Italy
▪ Spain
▪ Denmark
▪ Sweden
▪ Norway
▪ Japan
▪ India
▪ South Korea
▪ Australia
▪ Thailand
▪ Argentina
▪ UAE
▪ South Africa
▪ Kuwait
The need for cardiovascular repair and reconstruction devices has increased significantly. Innovations in device design and function, along with improvements in surgical techniques, are leading to more effective and efficient treatments. In addition, the expansion of healthcare infrastructure in emerging economies is facilitating greater access to these treatments.
In March 2026, Philips received U.S. FDA 510(k) clearance for its EchoNavigator R5.0 with DeviceGuide, an imaging and visualization solution that uses artificial intelligence (AI) to assist physicians during complex minimally invasive mitral valve repair procedures. The system enables real-time tracking and visualization of repair devices during surgery by integrating advanced imaging, AI-based guidance, and 3D visualization within a unified workflow. This development illustrates ongoing advancements in cardiovascular repair procedures, where advanced device guidance technologies enhance procedural precision, reduce complexity in valve repair interventions, and improve surgical outcomes.
The market is poised for substantial growth, driven by emerging trends in healthcare, including the application of AI in diagnostics and treatment planning, advancements in regenerative medicine and tissue engineering, and the rise of personalized medicine and therapy. Furthermore, the growing importance of biochemicals as essential components of treatment regimens is expected to fuel continued market expansion.
A study published in Circulation, the American Heart Association journal, in June 2024 highlighted the growing role of biomaterials and bioactive components in cardiovascular repair strategies. This includes engineered heart tissues, regenerative scaffolds, and biologically active coatings used in cardiac reconstruction therapies. The study emphasized that biochemical and bioengineered materials are increasingly being incorporated into cardiovascular repair devices to enhance tissue regeneration, improve biocompatibility, and support the functional recovery of damaged heart tissue. This reflects a broader shift toward combining device-based interventions with biochemical and regenerative therapeutic approaches in cardiovascular treatment.
Increased investment in research and development for peripheral arterial disease (PAD) holds significant promise for improving treatment efficacy and developing innovative solutions. Currently, angioplasty is the primary intervention for PAD; however, atherectomy offers an alternative method for addressing atherosclerotic plaque buildup. The focus on minimally invasive endovascular techniques to treat arterial blockages is driving innovation in the medical device industry and is expected to propel market growth in the coming years.
Cardiovascular Repair And Reconstruction Devices Market Report Segmentation
This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, the analyst has segmented the global construction repair and reconstruction devices market report based on product, and region:Product Outlook (Revenue, USD Billion, 2021 - 2033)
- Heart Valve Repair
- Vascular Graft
▪ Hemodialysis Access Graft
▪ Peripheral Vascular Graft
- Cardiovascular Patches
- Atrial Septal Defect
- Common Atrium
- Defects of the Endocardial Cushion
- Ventricular Septal Defect
- Tetralogy of Fallot
- Suture bleeding
- Carotid Endarterectomy
- Anomalous Connection of The Pulmonary Veins
- Transposition of the Great Vessels
- Reconstruction of Portal and Superior Mesenteric Veins
- Other Vascular Repair Applications
Regional Outlook (Revenue, USD Billion, 2021 - 2033)
- North America
▪ Canada
▪ Mexico
- Europe
▪ UK
▪ France
▪ Italy
▪ Spain
▪ Denmark
▪ Sweden
▪ Norway
- Asia Pacific
▪ Japan
▪ India
▪ South Korea
▪ Australia
▪ Thailand
- Latin America
▪ Argentina
- Middle East and Africa (MEA)
▪ UAE
▪ South Africa
▪ Kuwait
Why should you buy this report?
- Comprehensive Market Analysis: Gain detailed insights into the market across major regions and segments.
- Competitive Landscape: Explore the market presence of key players.
- Future Trends: Discover the pivotal trends and drivers shaping the future of the market.
- Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.
This report addresses:
- Market intelligence to enable effective decision-making
- Market estimates and forecasts from 2018 to 2030
- Growth opportunities and trend analyses
- Segment and regional revenue forecasts for market assessment
- Competition strategy and market share analysis
- Product innovation listing for you to stay ahead of the curve
Table of Contents
Chapter 1. Methodology and Scope
Chapter 2. Executive Summary
Chapter 3. Global Cardiovascular Repair and Construction Devices Market Variables, Trends, & Scope
Chapter 4. Global Cardiovascular Repair and Construction Devices Market: Product Estimates & Trend Analysis
Chapter 5. Global Cardiovascular Repair and Construction Devices Market: Regional Estimates & Trend Analysis
Chapter 6. Competitive Landscape
Companies Mentioned
- Medtronic plc
- BD.
- TERUMO CORPORATION
- W. L. Gore & Associates, Inc.
- Getinge
- Artivion, Inc
- Edwards Lifesciences Corporation
